Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  fluorine F 18 fluciclovine
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-8 of 8 for your search:
Start Over
FACBC Outcomes for Post Prostatectomy
Phase: Phase III, Phase II
Type: Diagnostic
Status: Active
Age: 18 to 95
Sponsor: Other
Protocol IDs: IRB00057680, 1R01CA169188-01, NCT01666808
FACBC for Recurrent Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IRB00061518, FACBC2, NCT01808222
Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma With PET and MRI
Phase: Phase II
Type: Diagnostic
Status: Active
Age: 50 to 85
Sponsor: Other
Protocol IDs: T70/2013, NCT02002455
A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 14-375, ONC-2013-119, NCT02346526
Anti-3-[18F]FACBC Imaging of Parathyroid Adenomas
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IRB00051415, NCT01574287
FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: 11-177, NCT01864083
FACBC for Head and Neck Cancers
Phase: No phase specified
Type: Diagnostic
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: IRB00062214, NCT01933269
Pre-operative PET-MR of High Risk Prostate Cancer Patients for Assessment of Cancer Aggressiveness and Lymph Node Status
Phase: No phase specified
Type: Diagnostic
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2013/1513, NCT02076503
Start Over